expert roundtables by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Treatment of fibrosis and pulmonary vascular disease is ripe for improvement. Our featured experts consider recent investigative work, looking forw......READ MORE
Outcomes in patients with chronic lung disease may have one or more drivers of greater relative importance, such as lung parenchymal/fibrotic disea......READ MORE
An important subset of patients with fibrotic interstitial lung disease (ILD) experience a decline in lung function with progressive symptoms and p......READ MORE
expert roundtables by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Connective tissue disease–associated interstitial lung disease (CTD-ILD) represents a nexus of subspecialty interests, where multidisciplinary care......READ MORE
expert roundtables by Charles D. Burger, MD; Steven D. Nathan, MD; and Justin Oldham, MD, MS
Predicting the progression of fibrotic lung disease and pulmonary vascular disease in interstitial lung disease (ILD) historically has been challen......READ MORE
Disease trajectories and outcomes in interstitial lung disease (ILD) are shaped by factors that include progressive fibrosis, comorbidities, and th......READ MORE
